Assisteo SAS has been acquired by DomusVi
DomusVi has acquired a 100% stake in Assisteo SAS, a private operator of home care services in France, for US$7 million.
With 23 branches throughout France, Assisteo is one of the three largest private players in France in a market dominated by non-profit organizations. They enjoy a reputation for high quality services and for a very efficient in-house developed IT system.
DomusVi manages 92 nursing homes, 20 home help agencies, six serviced accommodation units and ten establishments offering consultations, surgery and out-patient treatment in France and Quebec.
Oaklins' team in France advised the seller in this transaction. After an auction process, a short exclusivity period was offered to DomusVi who completed the transaction in two months.
Talk to the deal team
Related deals
SAP Landscapes has secured investment from Renatus Capital Partners
SAP Landscapes Limited has secured new investment from Renatus Capital Partners. The investment from Renatus will accelerate SAP Landscapes’ continued expansion, including geographic growth and the broadening of its services, both organically and through potential acquisitions or partnerships.
Learn moreNative Communities has been acquired by Greystar Real Estate Partners
Build-to-rent landlord Greystar Real Estate Partners has acquired Native Communities, a living sector and mixed-use management company, from Ares Real Estate. This acquisition strengthens Greystar’s third-party property management capabilities, accelerating its strategy to scale operations across key European markets. The combined business is uniquely positioned to support clients from single assets to complex, multi-country portfolios.
Learn moreInstituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn more